Latest Share Placements News

Galan Lithium has cleared all hurdles for a $20 million placement to Clean Elements Fund, unlocking funding to complete Phase 1 of its Hombre Muerto West lithium project with production slated for early 2026.

RLF AgTech Ltd has secured $4.5 million through a discounted share placement to support its strategic growth initiatives following a robust 74% revenue increase in FY2025. The company is advancing its Australian relaunch, expanding manufacturing, and entering new Asian markets.

RLF AgTech has successfully raised $4.5 million through a heavily oversubscribed placement, aiming to accelerate its Australian expansion and reduce leverage by cancelling convertible notes.

Cynata Therapeutics has entered a five-year At-the-Market Subscription Agreement with Acuity Capital, enabling access to up to $7.5 million in standby equity capital with full discretion over timing and pricing.

Arovella Therapeutics reported a 14% reduction in net loss to $7.5 million for FY25, bolstered by a $15 million capital raise to fund its lead iNKT cell therapy program progressing toward a pivotal phase 1 clinical trial.

Melbana Energy has successfully raised $7 million through a discounted share placement with attaching and bonus options, aiming to finance drilling at its Amistad-2 well and support general corporate needs.

Amaero Ltd has secured A$50 million through a share placement and plans a further A$3 million via a Share Purchase Plan to fast-track growth initiatives aligned with U.S. defense and manufacturing re-shoring priorities.

Orbital UAV secures $3 million through a share placement to boost manufacturing capabilities and expand business development amid new US drone market opportunities.

WIN Metals has secured $2.35 million through a heavily oversubscribed placement to accelerate drilling at its high-grade Radio Gold Mine and advance resource evaluation at Butchers Creek.

Kali Metals has successfully raised $1.2 million through a discounted share placement, aiming to boost exploration at its Marble Bar and Higginsville projects. The capital injection signals renewed momentum for the company’s gold and lithium ambitions.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

The Takeovers Panel has declined to investigate alleged breaches related to Yowie Group’s recent share placement and funding arrangements, finding no material impact on company control or disclosure issues.